Publications by authors named "Andrew Gomperts"
J Am Heart Assoc
May 2024
Article Synopsis
- Doxorubicin, a vital cancer treatment, can cause significant heart damage, but using low levels of carbon monoxide (CO) has been shown to offer protection against this toxicity.
- Researchers developed a new oral liquid drug (HBI-002) that allows patients to easily self-administer CO during doxorubicin treatment, aiming to address the challenges associated with traditional CO delivery methods.
- In tests on mice, HBI-002 notably increased CO levels in the heart, reduced damage from doxorubicin, and enhanced the drug's effectiveness against tumors, indicating it could be a valuable addition to cancer therapy without harming cardiac function.*
